Alvotech and Advanz Pharma Receive the EC’s Approval for Mynzepli (Biosimilar, Eylea)

Shots:The EC has approved Mynzepli (AVT06), a biosimilar version of Eylea (aflibercept) for all indications of the reference product in all 30 EEA states; AVT06’s Dossiers are under review in multiple regions incl. the US & JapanApproval was based on extensive analytical, non-clinical & clinical data incl. a confirmatory study assessing Mynzepli vs…

ByRidhi RastogiAugust 21, 2025

NEWS

The US FDA Approves Biocon Biologics’ Jobevne (Biosimilar, Avastin)

Shots:The US FDA has approved Jobevne, a biosimilar version of Avastin (bevacizumab) for IV administrationApproval was based on extensive data showing Jobevne is similar to Avastin in PK, safety, efficacy, structure, & function across clinical & analytical studiesJobevne (VEGF inhibitor) is marketed under the brand name Abevmy in the EU & Canada,…

ByRidhi RastogiApril 10, 2025

Alvotech and Advanz Pharma Receive the EC’s Approval for Mynzepli (Biosimilar, Eylea)

The US FDA Approves Biocon Biologics’ Jobevne (Biosimilar, Avastin)

Contact US

OUR INFORMATION

FOLLOW US